MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Michael O'Neill from IML and Ben Clark from TMS Private Wealth run the ruler over your most-tipped income stocks for 2025 ...

Those are the hard decisions. The ones where the questions or solutions aren’t always obvious, and no one on this board has been more consistent than I at asking those questions or making those ...

Hundreds of Australian companies are set reveal how much money they have earned or lost against the backdrop of major uncertainty from Trump's America.

Good day, and thank you for standing by. Welcome to the fourth quarter 2024 Unitil Corporation earnings conference call. At ...

Ian Lance, co-fund manager, Temple Bar Investment Trust shares his thoughts on on Pearson, Nvidia, Bitcoin and the 'cheap' UK ...

You have presented some substantive issues in the budget, but the minute you say something like a personal income tax cut, that grabs all the headlines. Yes, that is one, and also see normally, tax ...

They line up by the hundreds to meet recruiters at schools in provincial towns and convention halls in large cities, some ...

The parent firm's five-year risk-adjusted success ratio of 65% also strengthens the ... but they can be harder and more expensive to trade in bear markets. In this month, however, the strategy ...